Dmg Group, LLC Astrazeneca PLC Transaction History

Dmg Group, LLC

$121 Million
Q3 2024

A detailed history of Dmg Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Dmg Group, LLC holds 2,837 shares of AZN stock, worth $188,376. This represents 0.18% of its overall portfolio holdings.

Number of Shares

2,837

Previous 3,881 26.9%

Holding current value

$188,376

Previous $302,000 26.82%

% of portfolio

0.18%

Previous 0.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$76.67 - $87.62 $80,043 - $91,475	-1,044 Reduced 26.9%	2,837 $221,000
Q2 2024 Jul 16, 2024	SELL	$66.81 - $80.83 $2,204 - $2,667	-33 Reduced 0.84%	3,881 $302,000
Q1 2024 Apr 19, 2024	SELL	$61.03 - $69.57 $1,403 - $1,600	-23 Reduced 0.58%	3,914 $265,000
Q4 2023 Jan 10, 2024	SELL	$61.89 - $69.28 $18,505 - $20,714	-299 Reduced 7.06%	3,937 $265,000
Q3 2023 Oct 26, 2023	SELL	$64.85 - $71.7 $7,003 - $7,743	-108 Reduced 2.49%	4,236 $286,000
Q2 2023 Jul 13, 2023	SELL	$69.91 - $75.81 $9,018 - $9,779	-129 Reduced 2.88%	4,344 $310,000
Q1 2023 Apr 24, 2023	BUY	$63.15 - $71.6 $1,831 - $2,076	29 Added 0.65%	4,473 $313,000
Q4 2022 Feb 06, 2023	BUY	$54.21 - $70.44 $25,099 - $32,613	463 Added 11.63%	4,444 $308,000
Q3 2022 Oct 27, 2022	BUY	$53.02 - $135.75 $6,256 - $16,018	118 Added 3.05%	3,981 $221,000
Q2 2022 Aug 09, 2022	BUY	$59.26 - $71.14 $228,921 - $274,813	3,863 New	3,863 $255,000
Q1 2022 Apr 25, 2022	SELL	$55.72 - $67.12 $232,853 - $280,494	-4,179 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$54.02 - $63.83 $225,749 - $266,745	4,179 New	4,179 $248,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.

Account